Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 898-906

  Appel, Elena ^a   Vallon Eberhard, Alexandra ^a   Rabinkov, Aharon ^a   Brenner, Ori ^a   Shin, Irina ^a   Sasson, Keren ^a   Shadkchan, Yona ^b   Osherov, Nir ^b   Jung, Steffen ^a   Mirelman, David ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; ALLIIN; ALLIIN LYASE; ANTIBODY CONJUGATE; ASPERGILLUS FUMIGATUS MONOCLONAL ANTIBODY ALLIIN LYASE CONJUGATE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONCENTRATION RESPONSE; CONIDIUM; CONTROLLED STUDY; CYTOTOXICITY; DEATH; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNGUS HYPHAE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LUNG ASPERGILLOSIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; NOSE; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CARBON-SULFUR LYASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOCOMPROMISED HOST; KAPLAN-MEIERS ESTIMATE; MICE; MICE, INBRED ICR; PULMONARY ASPERGILLOSIS;

EID: 75749137693     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01267-09     Document Type: Article

References (55)

1. Ankri, S., and D. Mirelman. 1999. Antimicrobial properties of allicin from garlic. Microbes Infect. 1:125-129.
2. Ankri, S., T. Miron, A. Rabinkov, M. Wilchek, and D. Mirelman. 1997. Allicin from garlic strongly inhibits cysteine proteinases and cytopathic effects of Entamoeba histolytica. Antimicrob. Agents Chemother. 41:2286-2288.
3. Arditti, F. D., A. Rabinkov, T. Miron, Y. Reisner, A. Berrebi, M. Wilchek, and D. Mirelman. 2005. Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol. Cancer Ther. 4:325-331.
4. Bagshawe, K. D. 2006. Antibody-directed enzyme prodrug therapy (ADEPT) for cancer. Expert Rev. Anticancer Ther. 6:1421-1431.
5. Behnsen, J., P. Narang, M. Hasenberg, F. Gunzer, U. Bilitewski, N. Klippel, M. Rohde, M. Brock, A. A. Brakhage, and M. Gunzer. 2007. Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans. PLoS Pathogens 3:e13.
6. Bowden, R., P. Chandrasekar, M. H. White, X. Li, L. Pietrelli, M. Gurwith, J. A. van Burik, M. Laverdiere, S. Safrin, and J. R. Wingard. 2002. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin for treatment of invasive aspergillosis in immunocompromised patients. Clin. Infect. Dis. 35:359-366.
7. Cantón, E., A. Espinel-Ingroff, and J. Pemán. 2009. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev. Anti Infect. Ther. 7:107-119.
8. Cenci, E., A. Mencacci, A. Spreca, C. Montagnoli, A. Bacci, K. Perruiccio, A. Velardi, W. Magliani, S. Conti, L. Polonelli, and L. Romani. 2002. Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect. Immun. 70:2375-2382.
9. Chaturvedi, A. K., A. Kavishwar, G. B. Shiva Keshava, and P. K. Shukla. 2005. Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis. Clin. Diagn. Lab. Immunol. 12:1063-1068.
10. Daleine, G., D. Salmon, J. F. Lucet, P. Longuet, O. Bouchaud, C. Chochillon, and J. Le Bras. 1993. Frequency of bronchopulmonary isolation of Aspergillus species in patients infected with human immunodeficiency virus: pathogenic role? Pathol. Biol. (Paris) 41:237-241.
11. Davis, S. R. 2005. An overview of the antifungal properties of allicin and its breakdown products - the possibility of a safe and effective antifungal prophylactic. Mycoses 48:95-100.
12. Denning, D. W., K. A. Marr, W. M. Lau, D. P. Facklam, V. Ratanatharathorn, C. Becker, A. J. Ullmann, N. L. Seibel, P. M. Flynn, J. A. van Burik, D. N. Buell, and T. F. Patterson. 2006. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J. Infect. 53:337-349.
13. Enoch, D. A., H. A. Ludlam, and N. M. Brown. 2006. Invasive fungal infections; a review of epidemiology and management options. J. Med. Microbiol. 55:809-818.
14. Freeman, F., and Y. Kodera. 1995. Garlic chemistry - stability of S-(2-propenyl) 2-propene-1-sulfinothioate (allicin) in blood, solvents, and simulated physiological fluids. J. Agric. Food Chem. 43:2332-2338.
15. Harris, J. C., S. L. Cottrell, S. Plummer, and D. Lloyd. 2001. Antimicrobial properties of Allium sativum (garlic). Appl. Microbiol. Biotechnol. 57:282-286.
16. Heinz, W. J., and H. Einsele. 2008. Caspofungin for treatment of invasive Aspergillus infections. Mycoses 51:47-57.
17. Ho, W., and A. Furst. 1973. Intratracheal instillation method for mouse lungs. Oncology 27:385-393.
18. Ibrahim-Granet, O., B. Philippe, H. Boleti, E. Boisvieux-Ulrich, D. Grenet, M. Stern, and J. P. Latge. 2003. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect. Immun. 71: 891-903.
19. Kedziora, K., J. M. Slominski, K. Gil, M. Porzezinska, and A. Gorzewska. 2008. Invasive aspergillosis of the paranasal sinuses, lung and brain. Pneumonol. Alergol. Pol. 76:400-406.
20. Koch, H. P., and L. D. Lawson (ed.). 1996. Garlic: the science and therapeutic application of Allium sativum L. and related species, 2nd ed. Williams & Wilkins, Baltimore, MD.
21. Lambert, J. M., P. D. Senter, A. Yau-Young, W. A. Blattler, and V. S. Goldmacher. 1985. Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins. J. Biol. Chem. 260:12035-12041.
22. Latgé, J. P. 2001. The pathology of Aspergillus fumigatus. Trends Microbiol. 9:382-389.
23. Lewis, J. S. 2009. Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics. Med. Mycol. 47:S376-S381.
24. Lionakis, M. S., and D. P. Kontoyiannis. 2003. Glucocorticoids and invasive fungal infections. Lancet 362:1828-1838.
25. Maschmeyer, G., A. Haas, and O. A. Cornely. 2007. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67:1567-1601.
26. Matthews, R. C., G. Rigg, S. Hodgetts, T. Carter, C. Chapman, C. Gregory, C. Illidge, and J. Burnie. 2003. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob. Agents Chemother. 47:2208-2216.
27. Miron, T., M. Mironchik, D. Mirelman, M. Wilchek, and A. Rabinkov. 2003. Inhibition of tumor growth by a novel approach: in situ allicin generation using targeted alliinase delivery. Mol. Cancer Ther. 2:1295-1301.
28. Miron, T., A. Rabinkov, D. Mirelman, L. Weiner, and M. Wilchek. 1998. A spectrophotometric assay for allicin and alliinase (Alliin lyase) activity: reaction of 2-nitro-5-thiobenzoate with thiosulfinates. Anal. Biochem. 265: 317-325.
29. Miron, T., A. Rabinkov, D. Mirelman, M. Wilchek, and L. Weiner. 2000. The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim. Biophys. Acta 1463:20-30.
30. Miron, T., H. SivaRaman, A. Rabinkov, D. Mirelman, and M. Wilchek. 2006. A method for continuous production of allicin using immobilized alliinase. Anal. Biochem. 351:152-154.
31. Moen, M. D., K. A. Lyseng-Williamson, and L. J. Scott. 2009. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 69:361-392.
32. Moragues, M. D., M. J. Omaetxebarria, N. Elguezabal, M. J. Sevilla, S. Conti, L. Polonelli, and J. Pontón. 2003. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect. Immun. 71:5273-5279.
33. Mullins, J., and A. Seaton. 1978. Fungal spores in lung and sputum. Clin. Allergy 8:525-533.
34. Pietropaolo, M., C. D. Olson, B. S. Reiseter, M. T. Kasaian, and M. P. Happ. 2000. Intratracheal administration to the lung enhances therapeutic benefit of an MBP peptide in the treatment of murine experimental autoimmune encephalomyelitis. Clin. Immunol. 95:104-116.
35. Provencher, S. W. 1979. Inverse problems in polymer characterization: direct analysis of polydispersity with proton correlation spectroscopy. Makromol. Chem. 180:201-209.
36. Rabinkov, A., T. Miron, L. Konstantinovski, M. Wilchek, D. Mirelman, and L. Weiner. 1998. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim. Biophys. Acta 1379:233-244.
37. Rabinkov, A., T. Miron, D. Mirelman, M. Wilchek, S. Glozman, E. Yavin, and L. Weiner. 2000. S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim. Biophys. Acta 1499:144-153.
38. Rabinkov, A., M. Wilchek, and D. Mirelman. 1995. Alliinase (alliin lyase) from garlic (Alliium sativum) is glycosylated at ASN146 and forms a complex with a garlic mannose-specific lectin. Glycoconj. J. 12:690-698.
39. Rabinkov, A., X. Z. Zhu, G. Grafi, G. Galili, and D. Mirelman. 1994. Alliin lyase (Alliinase) from garlic (Allium sativum). Biochemical characterization and cDNA cloning. Appl. Biochem. Biotechnol. 48:149-171.
40. Romani, L. 2008. Cell mediated immunity to fungi: a reassessment. Med. Mycol. 46:515-529.
41. Saliba, F., and B. Dupont. 2008. Renal impairment and amphotericin B formulations in patients with invasive fungal infections. Med. Mycol. 46:97-112.
42. Schaffner, A., H. Douglas, A. I. Braude, and C. E. Davis. 1983. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 42:1109-1115.
43. Segal, B. H. 2007. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist 12:7-13.
44. Shadkchan, Y., E. Shemesh, D. Mirelman, T. Miron, A. Rabinkov, M. Wilchek, and N. Osherov. 2004. Efficacy of allicin, the reactive molecule of garlic, in inhibiting Aspergillus spp. in vitro, and in a murine model of disseminated aspergillosis. J. Antimicrob. Chemother. 53:832-836.
45. Shimon, L. J., A. Rabinkov, T. Miron, D. Mirelman, M. Wilchek, and F. Frolow. 2002. Alliin lyase (alliinase) from garlic (Allium sativum): crystallization and preliminary X-ray characterization. Acta Crystallogr. D Biol. Crystallogr. 58:1335-1337.
46. Shimon, L. J., A. Rabinkov, I. Shin, T. Miron, D. Mirelman, M. Wilchek, and F. Frolow. 2007. Two structures of alliinase from Allium sativum L: apo form and ternary complex with aminoacrylate reaction intermediate covalently bound to the PLP cofactor. J. Mol. Biol. 366:611-625.
47. Shoham, S., and S. M. Levitz. 2005. The immune response to fungal infections. Br. J. Haematol. 129:569-582.
48. Singh, N., and D. L. Paterson. 2005. Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. 18:44-69.
49. Song, Z., H. Wu, P. Mygind, D. Raventos, C. Sonksen, H. H. Kristensen, and N. Høiby. 2005. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection. Antimicrob. Agents Chemother. 49:3868-3874.
50. Steinbach, W. J., and D. A. Stevens. 2003. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin. Infect. Dis. 37:S157-S187.
51. Stoll, M., and E. Seebeck. 1951. Allium compounds V. The synthesis of natural alliin and its three optical isomers. Helv. Chim. Acta 34:481-487.
52. Tolman, J. A., N. P. Wiederhold, J. J. McConville, L. K. Najvar, R. Bocanegra, J. I. Peters, J. J. Coalson, J. R. Graybill, T. F. Patterson, and R. O. Williams III. 2009. Inhaled voriconazole for prevention of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 53:2613-2615.
53. Torosantucci, A., P. Chiani, C. Bromuro, F. De Bernardis, A. S. Palma, Y. Liu, G. Mignogna, B. Maras, M. Colone, A. Stringaro, S. Zamboni, T. Feizi, and A. Cassone. 2009. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 4:e5392.
54. Vallon-Eberhard, A., A. Makovitzki, A. Beauvais, J. P. Latge, S. Jung, and Y. Shai. 2008. Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-Lys-Ala-DAla- Lys. Antimicrob. Agents Chemother. 52:3118-3126.
55. Wasylnka, J. A., and M. M. Moore. 2003. Aspergillus fumigatus conidia survive and germinate in acidic organelles of A549 epithelial cells. J. Cell Sci. 116:1579-1587.